Tuberculosis and immune thrombocytopenia.
Madkaikar
Manisha
M
Institute of Immunohaematology, 13th Floor, New Multistoreyed Bldg, KEM Hospital Campus, Parel, Mumbai-400 012, India.
Ghosh
Kanjaksha
K
Jijina
Farah
F
Gupta
Maya
M
Rajpurkar
Madhavi
M
Mohanty
Dipika
D
D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000009:adverse effects; D001215:Asparaginase / Q000008:administration & dosage / Q000009:adverse effects; D015897:Comorbidity; D003630:Daunorubicin / Q000008:administration & dosage / Q000009:adverse effects; D015658:HIV Infections / Q000150:complications; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D015994:Incidence; D007194:India / Q000453:epidemiology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications / Q000188:drug therapy; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology*; D012189:Retrospective Studies; D012293:Rifampin / Q000009:adverse effects; D013921:Thrombocytopenia / Q000139:chemically induced; D014376:Tuberculosis / Q000150:complications / Q000453:epidemiology*; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects
D000305:Adrenal Cortex Hormones; D000995:Antitubercular Agents; D007166:Immunosuppressive Agents; D014750:Vincristine; D001215:Asparaginase; D011241:Prednisone; D012293:Rifampin; D003630:Daunorubicin